Related references
Note: Only part of the references are listed.Inhibition of Src/STAT3 signaling-mediated angiogenesis is involved in the anti-melanoma effects of dioscin
Yu-Xi Liu et al.
PHARMACOLOGICAL RESEARCH (2022)
Luteolin binds Src, promotes STAT3 protein ubiquitination and exerts anti-melanoma effects in cell and mouse models
Ting Li et al.
BIOCHEMICAL PHARMACOLOGY (2022)
Chrysoeriol suppresses hyperproliferation of rheumatoid arthritis fibroblast-like synoviocytes and inhibits JAK2/STAT3 signaling
Jia-Ying Wu et al.
BMC COMPLEMENTARY MEDICINE AND THERAPIES (2022)
Molecular Docking, Physicochemical Properties, Pharmacokinetics and Toxicity of Flavonoids Present in Euterpe oleracea Martius
Nayana Keyla Seabra de Oliveira et al.
CURRENT COMPUTER-AIDED DRUG DESIGN (2021)
The natural product trienomycin A is a STAT3 pathway inhibitor that exhibits potent in vitro and in vivo efficacy against pancreatic cancer
Qiu-Rui He et al.
BRITISH JOURNAL OF PHARMACOLOGY (2021)
A two-herb formula inhibits STAT3 signaling and exerts anti-melanoma effects in cell and animal models
Jun-Kui Li et al.
JOURNAL OF ETHNOPHARMACOLOGY (2021)
Inhibition of STAT3 enhances sensitivity to tamoxifen in tamoxifen-resistant breast cancer cells
Seo Yun Moon et al.
BMC CANCER (2021)
Chrysoeriol ameliorates TPA-induced acute skin inflammation in mice and inhibits NF-κB and STAT3 pathways
Wu Jia-Ying et al.
PHYTOMEDICINE (2020)
Anti-PD-1 and Novel Combinations in the Treatment of Melanoma-An Update
Frank Friedrich Gellrich et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Repurposing of niclosamide as a STAT3 inhibitor to enhance the anticancer effect of chemotherapeutic drugs in treating colorectal cancer
Mia M. Wu et al.
LIFE SCIENCES (2020)
A TCM formula comprising Sophorae Flos and Lonicerae Japonicae Flos alters compositions of immune cells and molecules of the STAT3 pathway in melanoma microenvironment
Yu-Xi Liu et al.
PHARMACOLOGICAL RESEARCH (2019)
Novel activators and small-molecule inhibitors of STAT3 in cancer
Lehe Yang et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2019)
STAT3 Interactors as Potential Therapeutic Targets for Cancer Treatment
Federica Laudisi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Two decades of research in discovery of anticancer drugs targeting STAT3, how close are we?
Jenny D. Beebe et al.
PHARMACOLOGY & THERAPEUTICS (2018)
Induction of apoptosis by morusin in human non-small cell lung cancer cells by suppression of EGFR/STAT3 activation
Hyun-Ji Park et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
Melanoma treatment: from conventional to nanotechnology
Harshita Mishra et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2018)
The natural polyphenol curcumin induces apoptosis by suppressing STAT3 signaling in esophageal squamous cell carcinoma
Ying Liu et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
Targeted agents and immunotherapies: optimizing outcomes in melanoma
Jason J. Luke et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Emerging targeted therapies for melanoma
Douglas B. Johnson et al.
EXPERT OPINION ON EMERGING DRUGS (2016)
Inhibition of the STAT3 signaling pathway contributes to apigenin-mediated anti-metastatic effect in melanoma
Hui-Hui Cao et al.
SCIENTIFIC REPORTS (2016)
JSI-124 (Cucurbitacin I) Inhibits Tumor Angiogenesis of Human Breast Cancer Through Reduction of STAT3 Phosphorylation
Jia Qi et al.
AMERICAN JOURNAL OF CHINESE MEDICINE (2015)
Cancer prevention and therapy through the modulation of the tumor microenvironment
Stephanie C. Casey et al.
SEMINARS IN CANCER BIOLOGY (2015)
FDA-approved small-molecule kinase inhibitors
Peng Wu et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2015)
Inhibition of STAT3 signalling contributes to the antimelanoma action of atractylenolide II
Xiu-Qiong Fu et al.
EXPERIMENTAL DERMATOLOGY (2014)
STAT3 Target Genes Relevant to Human Cancers
Richard L. Carpenter et al.
CANCERS (2014)
Revisiting STAT3 signalling in cancer: new and unexpected biological functions
Hua Yu et al.
NATURE REVIEWS CANCER (2014)
Pharmacokinetic study of luteolin, apigenin, chrysoeriol and diosmetin after oral administration of Flos Chrysanthemi extract in rats
Zhongjian Chen et al.
FITOTERAPIA (2012)
Discovery of Chrysoeriol, a PI3K-AKT-mTOR Pathway Inhibitor with Potent Antitumor Activity against Human Multiple Myeloma Cells in vitro
Yang Yang et al.
JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES (2010)
Inhibitory effects of chrysoeriol on DNA adduct formation with benzo[a]pyrene in MCF-7 breast cancer cells
Hitomi Takemura et al.
TOXICOLOGY (2010)
Diesel exhaust particulate-induced activation of Stat3 requires activities of EGFR and Src in airway epithelial cells
Dongsun Cao et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2007)
Small molecule inhibitors of Stat3 signaling pathway
Jinxia Deng et al.
CURRENT CANCER DRUG TARGETS (2007)
Chrysoeriol potently inhibits the induction of nitric oxide synthase by blocking AP-1 activation
DY Choi et al.
JOURNAL OF BIOMEDICAL SCIENCE (2005)
Targeting STAT3 affects melanoma on multiple fronts
M Kortylewski et al.
CANCER AND METASTASIS REVIEWS (2005)
The stats of cancer - New molecular targets come of age
H Yu et al.
NATURE REVIEWS CANCER (2004)
Share Paper
